Molecule Details
| InChIKey | UGFHIPBXIWJXNA-UHFFFAOYSA-N |
|---|---|
| Compound Name | Liarozole |
| Canonical SMILES | Clc1cccc(C(c2ccc3[nH]cnc3c2)n2ccnc2)c1 |
| Clinical Status | Data-mined Candidate |
| Targets (Human+Pathogen) | 6 |
| Pfam Stratification | Homologous |
| Avg pChEMBL | 7.24 |
| Source | ChEMBL;BindingDB |
2D Structure
Activity Profile
DrugBank Annotations
| DrugBank ID | DB13066 |
|---|---|
| Drug Name | Liarozole |
| CAS Number | 115575-11-6 |
| Groups | investigational |
| ATC Codes | nan |
| Description | Liarozole has been used in trials studying the treatment of Ichthyosis, Lamellar. |
Categories: Antineoplastic Agents Antineoplastic Agents, Hormonal Dermatologicals Enzyme Inhibitors Hormone Antagonists Hormones, Hormone Substitutes, and Hormone Antagonists
Cross-references: BindingDB: 50176808 ChEBI: 135316 CHEMBL389433 ChemSpider: 54664 PubChem:60652 PubChem:347829194 Wikipedia: Liarozole
Target Activities (6)
| Target | Gene | Organism | Category | Pfam | pChEMBL | Type | Source |
|---|---|---|---|---|---|---|---|
| Q07973 | CYP24A1 | Homo sapiens | Human | PF00067 | 8.6 | IC50 | ChEMBL;BindingDB |
| P11511 | CYP19A1 | Homo sapiens | Human | PF00067 | 8.3 | IC50 | ChEMBL;BindingDB |
| Q9NR63 | CYP26B1 | Homo sapiens | Human | PF00067 | 7.7 | IC50 | ChEMBL;BindingDB |
| P10632 | CYP2C8 | Homo sapiens | Human | PF00067 | 6.3 | IC50 | ChEMBL;BindingDB |
| O43174 | CYP26A1 | Homo sapiens | Human | PF00067 | 6.3 | IC50 | ChEMBL;BindingDB |
| P08684 | CYP3A4 | Homo sapiens | Human | PF00067 | 6.2 | IC50 | ChEMBL;BindingDB |